Future of sepsis therapies

Critical Care

Volumn 20, Issue 1, 2016, Pages

  van der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

SepsisTherapyBiomarke

Indexed keywords

BIOLOGICAL MARKER; IMMUNOMODULATING AGENT; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANTIBIOTIC THERAPY; COMORBIDITY; CRITICALLY ILL PATIENT; DISEASE COURSE; DRUG TARGETING; EDITORIAL; FATALITY; HUMAN; IMMUNE RESPONSE; INFECTION; INTENSIVE CARE UNIT; MACROPHAGE ACTIVATION SYNDROME; MORTALITY; NONHUMAN; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; PRIORITY JOURNAL; RESUSCITATION; SEPSIS; SURVIVAL; FORECASTING;

FORECASTING; HUMANS; SEPSIS;

EID: 84977479834     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-016-1274-9     Document Type: Editorial

References (11)

1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-10.
2. Marshall JC. Why have clinical trials in sepsis failed? Trends Mol Med. 2014;20(4):195-203.
3. Cohen J, Vincent JL, Adhikari NK, Machado FR, Angus DC, Calandra T, et al. Sepsis: a roadmap for future research. Lancet Infect Dis. 2015;15(5):581-614.
4. van der Poll T, Opal SM. Host-pathogen interactions in sepsis. Lancet Infect Dis. 2008;8(1):32-43.
5. Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13(12):862-74.
6. Davenport EE, Burnham KL, Radhakrishnan J, Humburg P, Hutton P, Mills TC, et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir Med. 2016. doi:10.1016/S2213-2600(16)00046-1.
7. Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, et al. Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial. Crit Care Med. 2016;44(2):275-81.
8. Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41(5):1167-74.
9. Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA. 2014;311(13):1308-16.
10. Yende S, Iwashyna TJ, Angus DC. Interplay between sepsis and chronic health. Trends Mol Med. 2014;20(4):234-8.
11. Deutschman CS, Tracey KJ. Sepsis: current dogma and new perspectives. Immunity. 2014;40(4):463-75.